blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4192982

EP4192982 - COMPOSITIONS AND METHODS FOR THE DETECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-2), INFLUENZA A, AND INFLUENZA B [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  12.05.2023
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  11.02.2022
Formerunknown
Status updated on  10.09.2021
Most recent event   Tooltip20.08.2024New entry: Renewal fee paid 
Applicant(s)For:AL  AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MK  MT  NL  NO  PL  PT  RO  RS  SE  SI  SK  SM  TR 
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
For:DE 
Roche Diagnostics GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
[2023/24]
Inventor(s)01 / HUANG, Renjian R H
Pleasanton, CA 94588 / US
02 / SUN, Jingtao
Pleasanton, CA 94588 / US
 [2023/24]
Representative(s)Hövelmann, Sascha Alexander
Roche Diagnostics GmbH
Patent Department (LPMM.....6164)
Sandhofer Straße 116
68305 Mannheim / DE
[2023/24]
Application number, filing date21763241.304.08.2021
[2023/24]
WO2021EP71733
Priority number, dateUS202063062105P06.08.2020         Original published format: US 202063062105 P
[2023/24]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2022029157
Date:10.02.2022
Language:EN
[2022/06]
Type: A2 Application without search report 
No.:EP4192982
Date:14.06.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 10.02.2022 takes the place of the publication of the European patent application.
[2023/24]
Search report(s)International search report - published on:EP09.06.2022
ClassificationIPC:C12Q1/70
[2023/24]
CPC:
C12Q1/701 (EP,US); C12Q2600/16 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/24]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUM NACHWEIS VON SCHWEREM AKUTEM RESPIRATORISCHEM SYNDROM CORONAVIRUS 2 (SARS-2), INFLUENZA A UND INFLUENZA B[2023/24]
English:COMPOSITIONS AND METHODS FOR THE DETECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-2), INFLUENZA A, AND INFLUENZA B[2023/24]
French:COMPOSITIONS ET PROCÉDÉS POUR DÉTECTER LE CORONAVIRUS 2 DU SYNDROME RESPIRATOIRE AIGU SÉVÈRE (SARS-2), DE LA GRIPPE A ET DE LA GRIPPE B[2023/24]
Entry into regional phase06.03.2023National basic fee paid 
06.03.2023Designation fee(s) paid 
06.03.2023Examination fee paid 
Examination procedure06.03.2023Examination requested  [2023/24]
06.03.2023Date on which the examining division has become responsible
08.09.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
22.08.2023Renewal fee patent year 03
20.08.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]CN111074005  (XI AN BORICARE CORNING BIOMEDICAL CENTER CO LTD) [A] 1-19 * sequence 13 *;
 [A]CN111118226  (BEIJING WEIWEILAI TECH CO LTD) [A] 1-19 * sequence 98 *;
 [I]CN111118228  (SHANGHAI BANGXIAN MEDICAL TECH CO LTD) [I] 1-19 * sequence 4 *;
 [A]CN111189900  (UNIV YUNNAN) [A] 1-19 * paragraph [0021] *;
 [A]CN111197112  (GUANGZHOU ANBIPING MEDICINE TECH CO LTD) [A] 1-19 * claims 1,6-9 *;
 [A]CN111218501  (XINYI MANUFACTURING TECH BEIJING CO LTD, et al) [A] 1-19 * figure 1; example 1; table 1 *;
 [A]CN111334609  (ZHENGZHOU CHILDRENS HOSPITAL OF HENAN CHILDRENS HOSPITAL) [A] 1-19 * claims 1, 3 *;
 [A]CN111334608  (BEIJING YISEN BIOTECHNOLOGY CO LTD) [A] 1-19 * claim 1 *;
 [A]CN111349719  (THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV GUANGZHOU RESPIRATORY CENTER, et al) [A] 1-19 * n_CoV-2019_44 *;
 [A]CN111378789  (GUANGZHOU HYBRIBIO PHARMACEUTICAL TECH CO LTD, et al) [A] 1-19 * claim 1 *;
 [A]CN111394522  (SANSURE BIOTECH INC) [A] 1-19 * claims 1-4; sequence 29 *;
 [I]CN111394519  (NANJING PRACTICE MEDICINE EXAMINATION CO LTD) [I] 1-19 * 2019-nCoV-ORF1ab-R *;
 [A]CN111394513  (INST PATHOGEN BIOLOGY CAMS) [A] 1-19 * sequence 6 *;
 [I]CN111394518  (CHENGDU YINTAI LIFE TECH CO LTD) [I] 1-19* sequence 4 *;
 [A]RU2727054  (DROZD SERGEJ FELIKSOVICH [RU]) [A] 1-19 * claims 1-8 *;
 [A]CN111454943  (PILOT GENE TECH HANGZHOU CO LTD) [A] 1-19 * claim 1; sequence 2 *;
 [E]WO2021168478  (LIFE TECHNOLOGIES CORP [US]) [E] 1-19 * claims 1-5 *;
 [E]WO2021180631  (HOFFMANN LA ROCHE [CH], et al) [E] 1-19 * claim 1; sequences 1,9,18,27-31,39 *;
 [E]WO2021243333  (BIOHSV HOLDINGS INC [US]) [E] 1 * sequence 116 *;
 [E]WO2022025823  (LUCENCE LIFE SCIENCES PTE LTD [SG]) [E] 1 * sequence 507 *;
 [A]  - Ranoa Diana Rose E. ET AL, "Saliva-Based Molecular Testing for SARS-CoV-2 that Bypasses RNA Extraction", bioRxiv, doi:10.1101/2020.06.18.159434, (20200618), pages 1 - 35, URL: https://www.biorxiv.org/content/10.1101/2020.06.18.159434v1.full.pdf, (20210813), XP055832042 [A] 1-19 * page 6 *

DOI:   http://dx.doi.org/10.1101/2020.06.18.159434
 [A]  - LAI CHIH-CHENG ET AL, "In vitro diagnostics of coronavirus disease 2019: Technologies and application", JOURNAL OF MICROBIOLOGY, IMMUNOLOGY AND INFECTION, ELSEVIER, AMSTERDAM, NL, vol. 54, no. 2, doi:10.1016/J.JMII.2020.05.016, ISSN 1684-1182, (20200605), pages 164 - 174, (20200605), XP086549959 [A] 1-19 * table 2 *

DOI:   http://dx.doi.org/10.1016/j.jmii.2020.05.016
 [A]  - N N, "Novel Coronavirus (SARS-CoV-2) Real-Time Multiplex RT-PCR Kit", Liferiver, (20200409), URL: https://www.who.int/diagnostics_laboratory/eual/eul_0486_139_00_novel_coronavirus_sars_cov_2_real_time_multiplex_rt_pcr_kit_ifu.pdf, XP055825772 [A] 1-19 * page 12 *
 [AP]  - Li Tao ET AL, "Rapid High Throughput Whole Genome Sequencing of SARS-CoV-2 by using One-step RT-PCR Amplification with Integrated Microfluidic System and Next-Gen Sequencing", bioRxiv, doi:10.1101/2020.11.04.369165, (20201105), URL: https://www.biorxiv.org/content/10.1101/2020.11.04.369165v1.full.pdf, (20211202), XP055868686 [AP] 1-19 * page 2 *

DOI:   http://dx.doi.org/10.1101/2020.11.04.369165
 [I]  - Zhao Zhen ET AL, "Abstract", bioRxiv, doi:10.1101/2020.02.22.961268, (20200227), pages 1 - 18, URL: https://www.biorxiv.org/content/10.1101/2020.02.22.961268v1.full.pdf, (20210210), XP055774509 [I] 1-19 * table 1 *

DOI:   http://dx.doi.org/10.1101/2020.02.22.961268
by applicantWO8403285
 US4996143
 US5210015
 US5565322
 US5849489
 US5994056
 US6001611
 US6162603
 US6171785
 US6184379
 US6748617
 US6780617
 US2010056383
 US7718421
 US7741467
 US10774393
    - LU, R. et al., Lancet, (20200000), vol. 395, pages 565 - 574
    - "GenBank", Database accession no. MN9089470
    - ALTSCHUL et al., "Basic local alignment search tool", J. Mol. Biol., (19900000), vol. 215, doi:10.1006/jmbi.1990.9999, pages 403 - 410, XP002949123

DOI:   http://dx.doi.org/10.1006/jmbi.1990.9999
    - GISH et al., "Identification of protein coding regions by database similarity search", Nature Genet, (19930000), vol. 3, pages 266 - 272
    - MADDEN et al., "Applications of network BLAST server", Meth. Enzymol., (19960000), vol. 266, doi:10.1016/S0076-6879(96)66011-X, pages 131 - 141, XP001006313

DOI:   http://dx.doi.org/10.1016/S0076-6879(96)66011-X
    - ALTSCHUL et al., "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res, (19970000), vol. 25, doi:10.1093/nar/25.17.3389, pages 3389 - 3402, XP002905950

DOI:   http://dx.doi.org/10.1093/nar/25.17.3389
    - ZHANG et al., "PowerBLAST: A new network BLAST application for interactive or automated sequence analysis and annotation", Genome Res, (19970000), vol. 7, pages 649 - 656
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.